authors Valdés-Ferrer, Sergio Iván Valdés-Ferrer, Sergio Iván Valdés-Ferrer, Sergio Iván Valdés-Ferrer, Sergio Iván Valdés-Ferrer, Sergio Iván Valdés-Ferrer, Sergio Iván
selected publications academic article in scopus Sepsis Impairs IFN-¿ Production in CD8 T Cells through Changes in Local Chromatin Landscape. Journal of Immunology. 2024 Brain metastasis risk prediction model in females with hormone receptor-positive breast cancer. Radiotherapy and Oncology. 2024 Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study. Frontiers in Medicine. 2023 Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial. Molecular Medicine. 28. 2022 Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients. Clinical Immunology. 225. 2021 A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol. BMC Infectious Diseases. 20. 2020
teaching activities Bases of the Nervous and Endocrine System Blood and Hematopoiesis Endocrine and Neural Ecosystem Immune Disorders Immune and Hematological Disorders' Pathophysiology Infectious Disease Pathophysiology Intermediate Stage Assessment - MC Week 18 Focus MC-5
education and training Doctor of Philosophy, Elmezzi Graduate School of Molecular Medicine Master of Internal Medicine, Universidad Nacional Autónoma de México Neurology, Universidad Nacional Autónoma de México Surgeon, Universidad Nacional Autónoma de México